In 2021, primary care providers, nurse practitioners, and physician assistants prescribed 6.5 million topical antifungal prescriptions to Medicare patients in the U.S.
“In the United States, nonrecommended topical antifungal prescribing is likely common, because diagnosis of cutaneous fungal infections by visual inspection is frequently incorrect, including among board-certified dermatologists, and clinicians across specialties rarely perform confirmatory diagnostic testing,” the CDC report states. “Understanding prescribing patterns, including identification of clinicians who prescribe a disproportionate volume of topical antifungals, might help establish and promote correct use of these medications.”
Prescribing rates of antifungal creams were highest in the South and Northeastern parts of the U.S., the report found.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
